Testosterone may affect transgender men’s immune system – LGBTQ Nation

by Curated September 15, 2024 · Gay News / Gay Pride / Gay Rights / LGBTQ Nation

As part of the Swedish study, researchers took blood samples from all 23 trans men before they started gender-affirming hormone therapy. After three months on testosterone, a second blood sample showed that most of the participants’ testosterone levels were comparable to those of cisgender men and that their estradiol and progesterone levels had decreased.

Stay connected to your community

Connect with the issues and events that impact your community at home and beyond by subscribing to our newsletter.

A third blood sample taken after 12 months on testosterone showed a decrease in an immune response involving type I interferon, a protein the body uses to fight viral infections, and an increase in a signaling pathway involving tumor necrosis factor, which is involved in fighting bacterial infections through inflammation, according to Scientific American.

Researchers also took blood samples from cisgender female donors and exposed them to either testosterone or an estrogen blocker. They found that testosterone appeared to be directly involved in an increase in the tumor necrosis factor response similar to what was shown in the trans men’s blood samples after 12 months. They also found that testosterone also affected the type I interferon response but noted that previous studies have suggested that estrogen may also be involved.

Essentially, the results of the study, published earlier this month in the journal Nature, suggest that taking testosterone may make people more vulnerable to viral infections while increasing their bodies’ ability to fight off bacterial infections.

However, the study’s authors urged caution. “We can’t say that these individuals are now more susceptible to any infection, and so on, but what we can say is that their immune profiles do alter or change in a way that is more similar to [cisgender] men,” co-author Petter Brodin, a professor of pediatric immunology at the Karolinska Institute in Stockholm, told Scientific American.

Dawn Newcomb, an assistant professor of medicine at Vanderbilt University Medical Center, who was not involved in the research, noted the study’s small sample size and added that sex hormones are “likely one mechanism—not the only mechanism—at play.”

Nils Landegren, an assistant professor at Uppsala University in Sweden who co-authored the study, cautioned against drawing conclusions about the risks of gender-affirming hormone therapy for transgender men without further information about actual disease outcomes. “We will need much larger numbers and longer follow-up,” he said.

“We should just urge caution for people taking hormone therapies for any purpose,” Brodin said, “and make sure that we follow up to see that there are no health consequences that we don’t intend.”

Don’t forget to share:

Actual Story on LGBTQ Nation
Author: John Russell